Antiphospholipid syndrome: frequency, main causes and risk factors of mortality.
The presence of antiphospholipid antibodies has been shown to be related to an increased risk of thrombotic events. In patients with definite antiphospholipid syndrome (APS), that is, those who have had thrombosis and at least two positive determinations of antiphospholipid antibodies, secondary thromboprophylaxis with long-term anticoagulation therapy results in a low rate of recurrent thrombotic events, ranging from 0.016 to 0.031 events per patient per year. Thrombotic complications are, however, the most common cause of death in APS. The mortality rate in a large European cohort of patients with APS during a 5-year study period was 5.3%, and up to 40% of the deaths in this cohort were attributed to severe thrombotic events such as myocardial infarction, stroke and pulmonary embolism. Catastrophic APS is an unusual form of the disease, being observed in less than 1% of reported cases of APS, which is associated with a much higher mortality rate than classical APS. The combined use of anticoagulation, corticosteroids, plasma exchange and intravenous immunoglobulin therapy could result in a dramatic reduction in mortality, by approximately 20%, in patients with catastrophic APS.
Espinosa
Gerard
G
Department of Autoimmune Diseases, Institut Clínic de Medicina i Dermatologia, Hospital Clínic, Villarroel, Barcelona, Catalonia, Spain.
Cervera
Ricard
R
D017152:Antibodies, Antiphospholipid; D016736:Antiphospholipid Syndrome / Q000453:epidemiology* / Q000209:etiology* / Q000401:mortality / Q000628:therapy; D006801:Humans; D012307:Risk Factors
D017152:Antibodies, Antiphospholipid
J Rheumatol. 2004 Aug;31(8):1560-7
15290736
Arthritis Rheum. 2006 Aug;54(8):2568-76
16868979
Ann Intern Med. 1992 Aug 15;117(4):303-8
1637025
Semin Thromb Hemost. 2008 Apr;34(3):290-4
18720310
Medicine (Baltimore). 1998 May;77(3):195-207
9653431
Arthritis Rheum. 2007 Dec 15;57(8):1487-95
18050167
Am J Med. 1998 Apr;104(4):332-8
9576405
Am J Med. 1998 Apr;104(4):381-5
9576413
Arch Intern Med. 2002 May 27;162(10):1164-9
12020188
Medicine (Baltimore). 2001 Nov;80(6):355-77
11704713
Ann Rheum Dis. 2009 Sep;68(9):1428-32
18801761
J Rheumatol. 2007 May;34(5):923-6
17477476
J Rheumatol. 2000 Dec;27(12):2817-21
11128669
J Thromb Haemost. 2006 Feb;4(2):295-306
16420554
Lupus. 2003;12(7):530-4
12892393
Arthritis Rheum. 2002 Apr;46(4):1019-27
11953980
Thromb Haemost. 2005 Apr;93(4):694-9
15841314
Lupus. 2009 Sep;18(10):905-12
19671791
Ann N Y Acad Sci. 2007 Jun;1108:448-56
17894009
J Rheumatol. 2007 Feb;34(2):346-52
17304658
N Engl J Med. 1995 Apr 13;332(15):993-7
7885428
J Autoimmun. 2009 Feb;32(1):1-6
19059760
J Rheumatol. 1992 Apr;19(4):508-12
1593568